About ACM Global Central Laboratory
ACM Global Central Laboratory is a Healthcare company based in New York (United States) founded in 1997. It provides bioanalytical, central lab, and toxicology services for global clinical trials. It operates on a B2B and Service-based model. The company has 10 employees. ACM Global Central Laboratory has completed 4 acquisitions, including ABS Laboratories, DRUGSCAN and DSI Medical Services. Its Indian entity Acm Global Laboratories Private Limited reported revenue of ₹7.11 Cr. ACM Global Central Laboratory offers products and services including Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits. Its focus areas include Biotechnology, Clinical Research, Lab Testing and Toxicology. Its competitors include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias and 5 more; 3 of its 10 listed competitors have raised funding.
Company details
ACM Global Laboratories delivers central lab services, bioanalytical testing, and toxicology solutions to support clinical trials across more than 65 countries. They specialize in assay development, biomarker analysis, and specimen management, partnering with pharmaceutical clients to optimize drug development programs. Based in locations like Rochester, NY, and York, UK, they ensure customized testing and data-driven decisions for healthcare research.
- Headquarters New York, United States
- Employees 10
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website acmgloballab.com
- Social X Facebook
- Legal Name Acm Global Laboratories Private Limited
- Date of Incorporation 08 Feb, 2011
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹7.11 Cr
FY 2025 · -1% YoY
- Net Profit₹6.2 Lakh
FY 2025 · 1% margin
- EBITDA₹25.1 Lakh
FY 2025 · 4% margin
- Employee Count10
- Investments & AcquisitionsABS Laboratories
& 3 more
Associated legal entities of ACM Global Central Laboratory
ACM Global Central Laboratory operates through Acm Global Laboratories Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acm Global Laboratories Private Limited CIN U73100MH2011PTC213163 | Active | 08 Feb 2011 | Mumbai, Maharashtra | ₹7.1 Cr | 10 | 2 | View details |
Products & Services of ACM Global Central Laboratory
ACM Global Central Laboratory offers a comprehensive portfolio of products and services, including Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits.
Analysis of large molecules in biological samples for drug development.
Testing for clinical trials including biomarker and safety analysis.
Evaluation of biomarkers to assess drug effects in trials.
Testing for drug levels and workplace substance analysis services.
Kits for efficient sample collection in clinical research studies.
Board of directors of Acm Global Laboratories Private Limited (ACM Global Central Laboratory)
Acm Global Laboratories Private Limited is the primary company behind ACM Global Central Laboratory. The board of Acm Global Laboratories Private Limited currently have 2 directors; the longest-serving is Nandan Gajapathy Rao, appointed in 2011. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nandan Gajapathy Rao DIN 03349484 | Director | 08 Feb 2011 | 15 yrs 8 mo | Acm Global Laboratories Private Limited |
| Sonal Shashikar Deshmukh DIN 05133122 | Director | 21 Dec 2011 | 14 yrs 9 mo | Acm Global Laboratories Private Limited |
People of ACM Global Central Laboratory
99 people are tracked at ACM Global Central Laboratory (29 in leadership, 70 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Ken Babineau | President | Leadership |
Regina Stocks Harrison | Associate Director | Leadership |
Justin Matlage | Director, Business Development | Leadership |
Daniel Lim | Laboratory Director | Leadership |
Aisha Summers Ms, Dhsc, Pmp® (c) | Associate Director, Clinical Trials Project Management | Leadership |
Sherry Douglas | VP, Global Quality | Leadership |
Scott Laneve | General Manager, DRUGSCAN | Leadership |
Thomas Mueller | Chief Commercial Officer And Chief Strategy Officer | Leadership |
Erica Smith | VP, Human Resources | Leadership |
Sian Estdale | Vice President, Global Clinical Operations | Leadership |
Kristin Traywick | Senior Director Finance | Leadership |
Corrie McCambridge | Vice President Of Sales For EMEA & APAC | Leadership |
Wayne Antinore | Director, IT Reporting And Analytics | Leadership |
Kama Post | Director, Center Of Excellence | Leadership |
Sara Degroot (Dirscherl) | Vice President Of Global Clinical Laboratory Operations | Leadership |
Abbas Mohammed | Senior Director Global Study Support | Leadership |
Melissa Glenz | Global Key Account Director | Leadership |
John H. | Associate Director, Laboratory Operations | Leadership |
Charlotte Perrin | Global Key Account Director | Leadership |
Jaysen Vollertsen | Vice President Of Finance | Leadership |
79 more people are available in the full profile.
Complete people profiles for ACM Global Central Laboratory
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ACM Global Central Laboratory
Figures of Acm Global Laboratories Private Limited, the primary company behind ACM Global Central Laboratory, for FY 2025. Revenue was ₹7.11 Cr (-1% year on year). Net profit was ₹6.2 Lakh (1% margin). EBITDA was ₹25.1 Lakh (4% margin). Revenue has grown at a compounded annual rate of +23% over three years and +23% over five years.
- ₹7.11 CrRevenue · FY 2025 · -1% YoY
- ₹6.2 LakhNet profit · 1% margin
- ₹25.1 LakhEBITDA · 4% margin
- ₹6 LakhPaid-up capital
- 10Employees (provident fund records)
- +23%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Acm Global Laboratories Private Limited are on its company page.
Detailed financial statements for ACM Global Central Laboratory
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ACM Global Central Laboratory
ACM Global Central Laboratory has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include ABS Laboratories, DRUGSCAN and DSI Medical Services.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bio-analytical service provider for in-vitro, preclinical and clinical studies | abslabs.co.uk | Welwyn Garden, United Kingdom | 1995 | Jun 2018 | •••• | |
Waste recycling services are provided since 1984 in Oak Ridge. | toxcommc.com | Oak Ridge, United States | 1984 | Jan 2018 | •••• | |
Provider of drug and alcohol testing, background checks, and DOT physicals | dsimed.com | Horsham, United States | 1991 | Dec 2017 | •••• | |
Provider of toxicology and prescription drug monitoring services | drugscan.com | Horsham, United States | 1985 | Dec 2017 | •••• |
Complete acquisition details for ACM Global Central Laboratory
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ACM Global Central Laboratory
5 dated milestones of ACM Global Central Laboratory across 21 years, from founding to its latest funding, stage changes and deals.
- Founded ACM Global Central Laboratory is founded.
- Acquisition Acquires DSI Medical Services.
- Acquisition Acquires DRUGSCAN.
- Acquisition Acquires ToxCommC.
- Acquisition Acquires ABS Laboratories.
Competitors of ACM Global Central Laboratory
ACM Global Central Laboratory has 10 listed competitors in our database, 3 of them funded. They include BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Solvias, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | – | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | |
| alderleyanalytical.com | 2013 | Stockport, United Kingdom | $869,352 | 41 | Bioanalytical assays for drug development are developed and validated. | |
| tentamus.com | 2011 | Berlin, Germany | – | 368 | Analytical and quality assurance services are provided for diverse industries. | |
| nordicbioscience.com | 1996 | Herlev, Denmark | – | 178 | Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | |
| solvias.com | 1999 | Kaiseraugst, Switzerland | – | – | Integrated R&D services are provided for pharmaceuticals and allied sectors. | |
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| synexagroup.com | 2003 | Cape Town, South Africa | – | – | Provider of comprehensive analytical and advisory services, specializing in biomarker services | |
| eag.com | 1978 | San Diego, United States | – | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| apocell.com | 2004 | Houston, United States | – | 2,198 | Provider of clinical trial and clinical development on bioanalytical services |
Detailed competitors of ACM Global Central Laboratory
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ACM Global Central Laboratory
The website of ACM Global Central Laboratory (acmgloballab.com) receives about 9.2K visits a month and ranks #2,731,952 among all websites worldwide, #3,690 in Biotechnology and Pharmaceuticals.
- Monthly visits9.2K
▲ 27.4% vs previous month
- Unique visitors2.8K
per month
- Global rank#2,731,952
among all websites
- Category rank#3,690
Health · Biotechnology and Pharmaceuticals
- Bounce rate34%
- Pages per visit2.2
- Average visit37 sec
- DevicesDesktop 41% · Mobile 59%
Websites whose visitors overlap most with ACM Global Central Laboratory. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| nucro-technics.com | 100% | 1.1K | – | View details | |
| lindushealth.com | 86% | 62.9K | #570,947 | View details |
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as ACM Global Central Laboratory (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acm Global Central Laboratory
Complete news archive for ACM Global Central Laboratory
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACM Global Central Laboratory
ACM Global Central Laboratory was founded in 1997.
ACM Global Central Laboratory is headquartered in New York, United States. It is registered at New York, New York, United States.
ACM Global Central Laboratory has 10 employees.
The primary company behind ACM Global Central Laboratory, Acm Global Laboratories Private Limited, reported revenue of ₹7.11 Cr for FY 2025, down 1% year on year.
ACM Global Laboratories delivers central lab services, bioanalytical testing, and toxicology solutions to support clinical trials across more than 65 countries. They specialize in assay development, biomarker analysis, and specimen management, partnering with pharmaceutical clients to optimize drug development programs. Based in locations like Rochester, NY, and York, UK, they ensure customized testing and data-driven decisions for healthcare research.
ACM Global Central Laboratory's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
ACM Global Central Laboratory offers Large Molecule Bioanalysis, Clinical Trial Testing, Pharmacodynamic Biomarker Analysis, Toxicology Services, and Customized Sample Collection Kits.
ACM Global Central Laboratory has made 4 acquisitions, including ABS Laboratories, DRUGSCAN, and DSI Medical Services.
ACM Global Central Laboratory operates through Acm Global Laboratories Private Limited.
The legal entities of ACM Global Central Laboratory currently have 2 directors, including Nandan Gajapathy Rao, Sonal Shashikar Deshmukh.